Bain Capital Specialty Finance, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Bain Capital Specialty Finance, Inc. on May 22, 2025. The filing details the voting outcomes for director elections and the decision to adjourn the meeting regarding a specific capital authorization proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
- Outstanding Shares: As of the record date (April 8, 2025), there were 64,868,506.64 shares of common stock entitled to vote.
- Proposal 1 (Election of Class III Directors): Stockholders re-elected David G. Fubini and Jeffrey B. Hawkins.
- David G. Fubini: 22,910,443.18 votes For; 9,916,106.00 votes Against.
- Jeffrey B. Hawkins: 31,965,249.52 votes For; 860,338.66 votes Against.
- Proposal 2 (Renew Authorization to Offer/Sell Shares Below NAV): The meeting was adjourned to solicit additional votes. No final result was reached at the May 22 meeting.
- Proposal 3 (Adjournment): Stockholders approved the adjournment with 22,365,214.18 votes For and 10,314,086.00 votes Against.
Outlook and Next Steps
The Company adjourned the Annual Meeting specifically to allow additional time to solicit stockholder votes for Proposal 2. A Reconvened Meeting is scheduled for June 12, 2025, at 2:30 p.m. Eastern Time. The meeting will be held virtually, and the record date remains April 8, 2025. Valid proxies from the original meeting remain valid for the reconvened session unless revoked.
Key Facts for Investor Verification
- Verify the outcome of Proposal 2 (Authorization to sell shares below Net Asset Value) at the reconvened meeting on June 12, 2025.
- Note the significant number of "Against" votes for David G. Fubini (approx. 9.9 million) compared to Jeffrey B. Hawkins (approx. 0.86 million).
- Confirm that existing proxies remain valid for the June 12 reconvened meeting.